Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G.

Lancet. 2010 May 15;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6.

PMID:
20472172
2.

Low cerebrovascular reserve capacity in long-term follow-up after subarachnoid hemorrhage.

Reinprecht A, Czech T, Asenbaum S, Podreka I, Schmidbauer M.

Surg Neurol. 2005 Aug;64(2):116-20; discussion 121.

PMID:
16051000
3.

Postictal psychosis in temporal lobe epilepsy.

Leutmezer F, Podreka I, Asenbaum S, Pietrzyk U, Lucht H, Back C, Benda N, Baumgartner C.

Epilepsia. 2003 Apr;44(4):582-90.

4.

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.

Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T.

World J Biol Psychiatry. 2002 Jul;3(3):133-46. Review.

PMID:
12478878
5.

Opioid addiction changes cerebral blood flow symmetry.

Pezawas L, Fischer G, Podreka I, Schindler S, Brücke T, Jagsch R, Thurnher M, Kasper S.

Neuropsychobiology. 2002;45(2):67-73.

PMID:
11893862
6.

SPECT and PET imaging of the dopaminergic system in Parkinson's disease.

Brücke T, Djamshidian S, Bencsits G, Pirker W, Asenbaum S, Podreka I.

J Neurol. 2000 Sep;247 Suppl 4:IV/2-7. Review.

PMID:
11199811
7.

Regional cerebral blood flow during temporal lobe seizures associated with ictal vomiting: an ictal SPECT study in two patients.

Baumgartner C, Olbrich A, Lindinger G, Pataraia E, Gröppel G, Bacher J, Aull S, Serles W, Hoffmann M, Leutmezer F, Czech T, Prayer D, Pietrzyk U, Asenbaum S, Podreka I.

Epilepsia. 1999 Aug;40(8):1085-91.

8.

Preictal SPECT in temporal lobe epilepsy: regional cerebral blood flow is increased prior to electroencephalography-seizure onset.

Baumgartner C, Serles W, Leutmezer F, Pataraia E, Aull S, Czech T, Pietrzyk U, Relic A, Podreka I.

J Nucl Med. 1998 Jun;39(6):978-82.

9.

Sertindole and dopamine D2 receptor occupancy in comparison to risperidone, clozapine and haloperidol - a 123I-IBZM SPECT study.

Kasper S, Tauscher J, Küfferle B, Barnas C, Hesselmann B, Asenbaum S, Podreka I, Brücke T.

Psychopharmacology (Berl). 1998 Apr;136(4):367-73.

PMID:
9600582
10.

Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison.

Asenbaum S, Brücke T, Pirker W, Pietrzyk U, Podreka I.

J Nucl Med. 1998 Apr;39(4):613-8.

11.

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol.

Küfferle B, Tauscher J, Asenbaum S, Vesely C, Podreka I, Brücke T, Kasper S.

Psychopharmacology (Berl). 1997 Oct;133(4):323-8.

PMID:
9372530
12.

Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.

Pirker W, Asenbaum S, Wenger S, Kornhuber J, Angelberger P, Deecke L, Podreka I, Brücke T.

J Nucl Med. 1997 Nov;38(11):1711-7.

13.

[Presurgical diagnosis of epilepsy and surgical epilepsy treatment].

Baumgartner C, Czech T, Feucht M, Schindler E, Podreka I.

Wien Klin Wochenschr. 1997 Mar 28;109(6):180-91. Review. German.

PMID:
9173667
14.
15.

Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.

Asenbaum S, Brücke T, Pirker W, Podreka I, Angelberger P, Wenger S, Wöber C, Müller C, Deecke L.

J Nucl Med. 1997 Jan;38(1):1-6.

16.

Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.

Pirker W, Riedl M, Luger A, Czech T, Rössler K, Asenbaum S, Angelberger P, Kornhuber J, Deecke L, Podreka I, Brücke T.

J Nucl Med. 1996 Dec;37(12):1931-7.

17.

Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone.

Küfferle B, Brücke T, Topitz-Schratzberger A, Tauscher J, Gössler R, Vesely C, Asenbaum S, Podreka I, Kasper S.

Psychiatry Res. 1996 Nov 25;68(1):23-30.

PMID:
9027930
18.

Epileptic negative myoclonus: An EEG-single-photon emission CT study indicating involvement of premotor cortex.

Baumgartner C, Podreka I, Olbrich A, Novak K, Serles W, Aull S, Almer G, Lurger S, Pietrzyk U, Prayer D, Lindinger G.

Neurology. 1996 Mar;46(3):753-8.

PMID:
8618677
19.

Technetium-99m-HMPAO SPECT imaging of cerebral blood flow during REM sleep in narcoleptics.

Asenbaum S, Zeithofer J, Saletu B, Frey R, Brücke T, Podreka I, Deecke L.

J Nucl Med. 1995 Jul;36(7):1150-5.

20.

D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study.

Brücke T, Wöber C, Podreka I, Wöber-Bingöl C, Asenbaum S, Aull S, Wenger S, Ilieva D, Harasko-van der Meer C, Wessely P, et al.

J Cereb Blood Flow Metab. 1995 May;15(3):513-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk